Related references
Note: Only part of the references are listed.EZH2 promotes cell proliferation by regulating the expression of RUNX3 in laryngeal carcinoma
Rong Lian et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)
Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment
Masatoshi Kudo et al.
LIVER CANCER (2017)
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Daniela Sia et al.
GASTROENTEROLOGY (2017)
LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells
Ching-Ju Shen et al.
JOURNAL OF DRUG TARGETING (2017)
EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis
C-H Shih et al.
ONCOGENE (2017)
Long non-coding RNA PVT I serves as a competing endogenous RNA for miR-I86-5p to promote the tumorigenesis and metastasis of hepatocellular carcinoma
Tian Lan et al.
TUMOR BIOLOGY (2017)
EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis
Kei Ihira et al.
ONCOTARGET (2017)
A comprehensive genome-wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma
Hongxia Cui et al.
CANCER MEDICINE (2017)
Long noncoding RNA PVT1 promotes hepatocellular carcinoma progression through regulating miR-214
Xun Gou et al.
CANCER BIOMARKERS (2017)
Long noncoding RNA PCAT-1 promotes invasion and metastasis via the miR-129-5p-HMGB1 signaling pathway in hepatocellular carcinoma
Deyuan Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Long non-coding RNA PVT1 indicates a poor prognosis of glioma and promotes cell proliferation and invasion via target EZH2
Anqiang Yang et al.
BIOSCIENCE REPORTS (2017)
LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer
Jin Yang et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2017)
EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses' Health Studies
Francisco Beca et al.
BREAST CANCER RESEARCH (2017)
Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR)
Qinyi Zhou et al.
TUMOR BIOLOGY (2016)
Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression
Li Wan et al.
MOLECULAR CANCER THERAPEUTICS (2016)
The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosis
Run Zhai et al.
ONCOTARGETS AND THERAPY (2016)
LncBRM initiates YAP1 signalling activation to drive self-renewal of liver cancer stem cells
Pingping Zhu et al.
NATURE COMMUNICATIONS (2016)
Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16
Rong Kong et al.
MOLECULAR CANCER (2015)
Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients
Chaofeng Ding et al.
ONCOLOGY LETTERS (2015)
Oncofetal Long Noncoding RNA PVT1 Promotes Proliferation and Stem Cell-Like Property of Hepatocellular Carcinoma Cells by Stabilizing NOP2
Fang Wang et al.
HEPATOLOGY (2014)
EZH2: An Epigenetic Gatekeeper Promoting Lymphomagenesis
Holger Heyn et al.
CANCER CELL (2013)
EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin-Dependent Hepatocarcinogenesis
Alfred S. L. Cheng et al.
CANCER RESEARCH (2011)
Molecular Mechanisms of Long Noncoding RNAs
Kevin C. Wang et al.
MOLECULAR CELL (2011)
Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes
Miao-Chih Tsai et al.
SCIENCE (2010)
Share Paper
